{"id":517961,"date":"2021-07-27T07:04:07","date_gmt":"2021-07-27T11:04:07","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-announce-second-quarter-2021-financial-results-on-august-5-2021\/"},"modified":"2021-07-27T07:04:07","modified_gmt":"2021-07-27T11:04:07","slug":"amicus-therapeutics-to-announce-second-quarter-2021-financial-results-on-august-5-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-announce-second-quarter-2021-financial-results-on-august-5-2021\/","title":{"rendered":"Amicus Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">PHILADELPHIA, July  27, 2021  (GLOBE NEWSWIRE) &#8212; Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Thursday, August 5, 2021 at 8:30 a.m. ET to discuss financial results for the second quarter ended June 30, 2021.<\/p>\n<p>Interested participants and investors may access the conference call by dialing 877-303-5859 (U.S.\/Canada) or 678-224-7784 (international), conference ID: 7374935. A live audio webcast and related presentation materials can also be accessed via the Investors section of the Amicus Therapeutics corporate website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3zgdtBi2ovE5a8PwNSWCPt-A_-sK1vXREF_LIDPH7tcDoM-dSBMaqrpJBA4Jp1F4OMQKqbIfNY9vz-pwqPO-1g==\" rel=\"nofollow noopener\" target=\"_blank\">ir.amicusrx.com<\/a>. Web participants are encouraged to register on the website 15 minutes prior to the start of the call.<\/p>\n<p>A replay of the call will be available for seven days beginning at 11:30 a.m. ET. Access numbers for this replay are 855-859-2056 (U.S.\/Canada) and 404-537-3406 (international); conference ID: 7374935.<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>About Amicus Therapeutics <\/u><br \/>\n        <\/strong><br \/>\n        <br \/>Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases. For more information please visit the company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Ja1ipksjWXPF3UpiR5wgqKUu9SQBbHRsVHN7I9Qk_L_dNriF_SDkAVi88C71Cuo9choSca-A-UuvdQ4_amVE_Q==\" rel=\"nofollow noopener\" target=\"_blank\">www.amicusrx.com<\/a>, and follow on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=y0YZ_U4EaKz10lprr9O5jb10JKh63DxzSXyME0RCvyn99mVDeSkamLltDp7WX1Q2TZOOW-Rm67wnOZXP0fH8xw==\" rel=\"nofollow noopener\" target=\"_blank\">Twitter<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2_K1ic9mtFhvHIQZ8AlGTRR4jyFGo-1spfzuSyzblbVR3c8JGPmKWipFlf8-G1uVzAm4zRckhOU_lvmatmmflip3AaIbAcmjT_Dpf8VSk62m99xSqb55BM_bt-iyBBSa\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p align=\"justify\">CONTACT:<\/p>\n<p align=\"justify\">\n        <strong>Investors<\/strong>:<br \/>Andrew Faughnan<br \/>Executive Director, Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AwJjvCua8Fv2vFWtOXHeT5OjHhC0BkHahucDSBwQx2eVNZAKDa7vdZ-Bimtgs-CvJ6dNr0ar7DbhHBaUYJx_CaPhc7cgbPkgF6jRahmJuLA=\" rel=\"nofollow noopener\" target=\"_blank\">afaughnan@amicusrx.com<\/a><br \/>(609) 662-3809<\/p>\n<p align=\"justify\">\n        <strong>Media<\/strong>:<br \/>Diana Moore<br \/>Head of Global Corporate Affairs &amp; Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jdUg-pkpEUobRpxYBjhU0PfXh6jy3tlRlviixBvyj2zZllpp_INy0yQfoY3Cc4-sQkMwM3o-7npZcYnOgo44Y0rzI-bGwMPnQyrg1S3YTBg=\" rel=\"nofollow noopener\" target=\"_blank\">dmoore@amicusrx.com<\/a><br \/>(609) 662-5079<\/p>\n<p align=\"justify\">FOLD\u2013G<\/p>\n<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NjkxMiM0MzE1Mzc3IzIwMDU2NTg=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/68037832-5742-4460-b936-ad35c53c71ef\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PHILADELPHIA, July 27, 2021 (GLOBE NEWSWIRE) &#8212; Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Thursday, August 5, 2021 at 8:30 a.m. ET to discuss financial results for the second quarter ended June 30, 2021. Interested participants and investors may access the conference call by dialing 877-303-5859 (U.S.\/Canada) or 678-224-7784 (international), conference ID: 7374935. A live audio webcast and related presentation materials can also be accessed via the Investors section of the Amicus Therapeutics corporate website at ir.amicusrx.com. Web participants are encouraged to register on the website 15 minutes prior to the start of the call. A replay of the call will be available for seven days beginning at &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-announce-second-quarter-2021-financial-results-on-august-5-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Amicus Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-517961","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Amicus Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-announce-second-quarter-2021-financial-results-on-august-5-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Amicus Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PHILADELPHIA, July 27, 2021 (GLOBE NEWSWIRE) &#8212; Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Thursday, August 5, 2021 at 8:30 a.m. ET to discuss financial results for the second quarter ended June 30, 2021. Interested participants and investors may access the conference call by dialing 877-303-5859 (U.S.\/Canada) or 678-224-7784 (international), conference ID: 7374935. A live audio webcast and related presentation materials can also be accessed via the Investors section of the Amicus Therapeutics corporate website at ir.amicusrx.com. Web participants are encouraged to register on the website 15 minutes prior to the start of the call. A replay of the call will be available for seven days beginning at &hellip; Continue reading &quot;Amicus Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-announce-second-quarter-2021-financial-results-on-august-5-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-27T11:04:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NjkxMiM0MzE1Mzc3IzIwMDU2NTg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amicus-therapeutics-to-announce-second-quarter-2021-financial-results-on-august-5-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amicus-therapeutics-to-announce-second-quarter-2021-financial-results-on-august-5-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Amicus Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021\",\"datePublished\":\"2021-07-27T11:04:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amicus-therapeutics-to-announce-second-quarter-2021-financial-results-on-august-5-2021\\\/\"},\"wordCount\":247,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amicus-therapeutics-to-announce-second-quarter-2021-financial-results-on-august-5-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NjkxMiM0MzE1Mzc3IzIwMDU2NTg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amicus-therapeutics-to-announce-second-quarter-2021-financial-results-on-august-5-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amicus-therapeutics-to-announce-second-quarter-2021-financial-results-on-august-5-2021\\\/\",\"name\":\"Amicus Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amicus-therapeutics-to-announce-second-quarter-2021-financial-results-on-august-5-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amicus-therapeutics-to-announce-second-quarter-2021-financial-results-on-august-5-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NjkxMiM0MzE1Mzc3IzIwMDU2NTg=\",\"datePublished\":\"2021-07-27T11:04:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amicus-therapeutics-to-announce-second-quarter-2021-financial-results-on-august-5-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amicus-therapeutics-to-announce-second-quarter-2021-financial-results-on-august-5-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amicus-therapeutics-to-announce-second-quarter-2021-financial-results-on-august-5-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NjkxMiM0MzE1Mzc3IzIwMDU2NTg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NjkxMiM0MzE1Mzc3IzIwMDU2NTg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amicus-therapeutics-to-announce-second-quarter-2021-financial-results-on-august-5-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Amicus Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Amicus Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-announce-second-quarter-2021-financial-results-on-august-5-2021\/","og_locale":"en_US","og_type":"article","og_title":"Amicus Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021 - Market Newsdesk","og_description":"PHILADELPHIA, July 27, 2021 (GLOBE NEWSWIRE) &#8212; Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Thursday, August 5, 2021 at 8:30 a.m. ET to discuss financial results for the second quarter ended June 30, 2021. Interested participants and investors may access the conference call by dialing 877-303-5859 (U.S.\/Canada) or 678-224-7784 (international), conference ID: 7374935. A live audio webcast and related presentation materials can also be accessed via the Investors section of the Amicus Therapeutics corporate website at ir.amicusrx.com. Web participants are encouraged to register on the website 15 minutes prior to the start of the call. A replay of the call will be available for seven days beginning at &hellip; Continue reading \"Amicus Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-announce-second-quarter-2021-financial-results-on-august-5-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-27T11:04:07+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NjkxMiM0MzE1Mzc3IzIwMDU2NTg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-announce-second-quarter-2021-financial-results-on-august-5-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-announce-second-quarter-2021-financial-results-on-august-5-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Amicus Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021","datePublished":"2021-07-27T11:04:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-announce-second-quarter-2021-financial-results-on-august-5-2021\/"},"wordCount":247,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-announce-second-quarter-2021-financial-results-on-august-5-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NjkxMiM0MzE1Mzc3IzIwMDU2NTg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-announce-second-quarter-2021-financial-results-on-august-5-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-announce-second-quarter-2021-financial-results-on-august-5-2021\/","name":"Amicus Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-announce-second-quarter-2021-financial-results-on-august-5-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-announce-second-quarter-2021-financial-results-on-august-5-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NjkxMiM0MzE1Mzc3IzIwMDU2NTg=","datePublished":"2021-07-27T11:04:07+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-announce-second-quarter-2021-financial-results-on-august-5-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-announce-second-quarter-2021-financial-results-on-august-5-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-announce-second-quarter-2021-financial-results-on-august-5-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NjkxMiM0MzE1Mzc3IzIwMDU2NTg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NjkxMiM0MzE1Mzc3IzIwMDU2NTg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amicus-therapeutics-to-announce-second-quarter-2021-financial-results-on-august-5-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Amicus Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/517961","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=517961"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/517961\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=517961"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=517961"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=517961"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}